Alnylam Pharmaceuticals
ALNY
#727
Rank
โ‚น3.358 T
Marketcap
โ‚น25,098
Share price
-0.65%
Change (1 day)
-36.25%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company